Oxidative Phosphorylation Targeting In Malignant Glioma Using Metformin Plus Radiotherapy Temozolomide

Abroad (travel likely)RecruitingPHASE2

Conditions

Glioblastoma, IDH-wildtype

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Foch Hospital, Suresnes, Hauts de Seine, France
Contact: Study coordinator (Nadia YOUNAN, MD) · n.younan@hopital-foch.com · 01 46 25 31 41
Hôpital Neurologique Pierre Wertheimer, Bron, Lyon, France
Contact: Study coordinator (François DUCRAY, PUPH) · francois.ducray@chu-lyon.fr
Timone Hospital, Marseille, Marseille, France
Contact: Study coordinator (Olivier CHINOT, PUPH) · olivier.chinot@ap-hm.fr
Saint Louis Hospital, Paris, Paris, France
Contact: Study coordinator (Stefania Cuzzubbo, PUPH) · stefania.cuzzubbo@aphp.fr@aphp.fr · 0171207466
Pitié Salpêtrière Hospital, Paris, PARIS, France
Contact: Study coordinator (Marc SANSON, PUPH) · marc.sanson@aphp.fr
Istituto Nazionale Carlo Besta, Milan, Milano, Italy
Contact: Study coordinator (Marica EOLI, MD) · marica.eoli@istituto-besta.it
Spidali Riuniti Di Livorno, Livorno, Toscana Nord Ouest, Italy
Contact: Study coordinator (Anna Luisa DI STEFANO) · annaluisa.distefano@uslnordovest.toscana.it

Study leads

Anna Luisa DI STEFANO, MD
Principal Investigator
Foch Hospital

View source on ClinicalTrials.gov Contact study team (email)